Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 … – The Lancet,

This study is registered with Clinicaltrials.gov, NCT01196390; … for Oesophageal cancer followed by Surgery Study (CROSS) trial showed an …, This study is registered with Clinicaltrials.gov, NCT01196390; … for Oesophageal cancer followed by Surgery Study (CROSS) trial showed an …, Read More

Scroll to Top